Grigory Efimov
Grigory Efimov
Hematology Research Center
Подтвержден адрес электронной почты в домене
Cell-type–restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
GA Efimov, AA Kruglov, ZV Khlopchatnikova, FN Rozov, VV Mokhonov, ...
Proceedings of the National Academy of Sciences 113 (11), 3006-3011, 2016
Tumor necrosis factor, lymphotoxin and cancer
MS Drutskaya, GA Efimov, AA Kruglov, DV Kuprash, SA Nedospasov
IUBMB life 62 (4), 283-289, 2010
SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors
AS Shomuradova, MS Vagida, SA Sheetikov, KV Zornikova, D Kiryukhin, ...
Immunity 53 (6), 1245-1257. e5, 2020
Tumor Necrosis Factor and the consequences of its ablation in vivo
GA Efimov, AA Kruglov, SV Tillib, DV Kuprash, SA Nedospasov
Molecular immunology 47 (1), 19-27, 2009
Modern anti-cytokine therapy of autoimmune diseases
IV Astrakhantseva, GA Efimov, MS Drutskaya, AA Kruglov, ...
Biochemistry (Moscow) 79 (12), 1308-1321, 2014
VHH-based bispecific antibodies targeting cytokine production
MA Nosenko, KSN Atretkhany, VV Mokhonov, GA Efimov, AA Kruglov, ...
Frontiers in immunology 8, 1073, 2017
Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection
AA Minervina, EA Komech, A Titov, MB Koraichi, E Rosati, IZ Mamedov, ...
Elife 10, e63502, 2021
Methods for in vivo molecular imaging
AA Kuchmiy, GA Efimov, SA Nedospasov
Biochemistry (Moscow) 77 (12), 1339-1353, 2012
Single-domain antibody-based ligands for immunoaffinity separation of recombinant human lactoferrin from the goat lactoferrin of transgenic goat milk
SV Tillib, ME Privezentseva, TI Ivanova, LF Vasilev, GA Efimov, ...
Journal of Chromatography B 949, 48-57, 2014
Interleukin-6: From molecular mechanisms of signal transduction to physiological properties and therapeutic targeting
MS Drutskaya, MA Nosenko, KSN Atretkhany, GA Efimov, ...
Molecular Biology 49 (6), 837-842, 2015
Experimental models of arthritis in which pathogenesis is dependent on TNF expression
MS Drutskaya, GA Efimov, RV Zvartsev, AA Chashchina, DM Chudakov, ...
Biochemistry (Moscow) 79 (12), 1349-1357, 2014
Can we design a better anti‐cytokine therapy?
MS Drutskaya, GA Efimov, AA Kruglov, SA Nedospasov
Journal of leukocyte biology 102 (3), 783-790, 2017
Cancer immunotherapy based on the blockade of immune checkpoints
AV Bogolyubova, GA Efimov, MS Drutskaya, SA Nedospasov
Medical Immunology (Russia) 17 (5), 395-406, 2015
Modalities of experimental TNF blockade in vivo: Mouse models
AA Kruglov, AV Tumanov, SI Grivennikov, YV Shebzukhov, AA Kuchmiy, ...
Advances in TNF Family Research, 421-431, 2011
Making anti-cytokine therapy more selective: Studies in mice
MS Drutskaya, GA Efimov, IV Astrakhantseva, AA Kruglov, ...
Cytokine 101, 33-38, 2018
In silico analysis of the minor histocompatibility antigen landscape based on the 1000 Genomes Project
NA Bykova, DB Malko, GA Efimov
Frontiers in immunology 9, 1819, 2018
Isolation and characteristics of a new recombinant single domain antibody that specifically binds to human TNF
GA Efimov, ZV Khlopchatnikova, AY Sazykin, MC Drutskaya, AA Kruglov, ...
Russ. J. Immunol 6, 337-345, 2012
Rapid multiplex genotyping of 20 HLA-A* 02: 01 restricted minor histocompatibility antigens
DS Romaniuk, AM Postovskaya, AA Khmelevskaya, DB Malko, GA Efimov
Frontiers in immunology 10, 1226, 2019
Modification of Cytotoxic Lymphocytes with T Cell Receptor Specific for Minor Histocompatibility Antigen ACC-1Y
AM Pilunov, AA Kuchmiy, SA Sheetikov, SY Filkin, DS Romaniuk, ...
Molecular Biology 53 (3), 402-410, 2019
Recombinant MHC tetramers for isolation of virus-specific CD8+ cells from healthy donors: Potential approach for cell therapy of posttransplant cytomegalovirus infection
AS Vdovin, SY Filkin, PR Yefimova, SA Sheetikov, NM Kapranov, ...
Biochemistry (Moscow) 81 (11), 1371-1383, 2016
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20